ASP Isotopes (ASPI) Set to Release Quarterly Earnings on Thursday

ASP Isotopes (NASDAQ:ASPI) is expected to be announcing its Q3 2026 resultson Thursday, November 12th. Analysts expect ASP Isotopes to announce earnings of ($0.15) per share and revenue of $5.68 million for the quarter. Interested persons can check the company’s upcoming Q3 2026 earnings report for the latest details on the call scheduled for Friday, November 20, 2026 at 8:30 AM ET.

ASP Isotopes (NASDAQ:ASPI) last issued its quarterly earnings results on Friday, August 14th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.17) by ($0.11). The company had revenue of $5.12 million during the quarter, compared to the consensus estimate of $4.47 million. ASP Isotopes had a negative net margin of 427.98% and a negative return on equity of 64.99%.

ASP Isotopes Stock Performance

Shares of NASDAQ:ASPI opened at $2.14 on Tuesday. The business’s 50 day simple moving average is $2.73 and its 200 day simple moving average is $4.71. ASP Isotopes has a 1 year low of $1.66 and a 1 year high of $9.28. The company has a debt-to-equity ratio of 0.76, a current ratio of 3.87 and a quick ratio of 3.85.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on ASPI shares. Wall Street Zen upgraded ASP Isotopes from a “strong sell” rating to a “sell” rating in a research report on Saturday, August 22nd. Weiss Ratings reissued a “sell (d-)” rating on shares of ASP Isotopes in a report on Monday, September 21st. Two equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $12.00.

Insider Activity

In other news, COO Robert Ainscow sold 25,000 shares of the business’s stock in a transaction that occurred on Wednesday, September 2nd. The shares were sold at an average price of $3.90, for a total value of $97,500.00. Following the completion of the transaction, the chief operating officer directly owned 2,256,879 shares in the company, valued at approximately $8,801,828.10. The trade was a 1.10% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Paul Mann sold 83,759 shares of the company’s stock in a transaction that occurred on Friday, September 4th. The stock was sold at an average price of $4.10, for a total transaction of $343,411.90. Following the sale, the chief executive officer directly owned 9,328,570 shares of the company’s stock, valued at approximately $38,247,137. This trade represents a 0.89% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 245,285 shares of company stock valued at $899,887 in the last 90 days. 14.40% of the stock is owned by corporate insiders.

About ASP Isotopes

ASP Isotopes Inc is a materials and technology company developing isotope-enrichment processes for use in the medical, semiconductor and nuclear-energy industries. Its primary technology is the Aerodynamic Separation Process, a proprietary method designed to separate isotopes based on differences in molecular mass and aerodynamic behavior.

The company is pursuing the production of enriched isotopes, including materials intended for applications such as semiconductor manufacturing, medical diagnostics and treatment, advanced nuclear fuels, and other industrial and scientific uses.